Albuminuria Clinical Trial
Official title:
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00095290 -
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
|
Phase 4 | |
| Completed |
NCT02144740 -
Effect of NWT-03 on Blood Pressure
|
N/A | |
| Completed |
NCT01041599 -
Correlation of Albuminuria With Arterial Stiffness
|
N/A | |
| Active, not recruiting |
NCT05321095 -
Screening for Albuminuria at the First Line for Early Identification of CKD
|
||
| Completed |
NCT02945969 -
Sodium Lowering and Urinary Protein Reduction Trial
|
Phase 3 | |
| Enrolling by invitation |
NCT04295889 -
Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches
|
N/A | |
| Recruiting |
NCT04272359 -
Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
|
||
| Completed |
NCT03889236 -
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
|
N/A | |
| Active, not recruiting |
NCT00625820 -
Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
|
Phase 2 | |
| Recruiting |
NCT04752293 -
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
|
||
| Completed |
NCT03118739 -
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
|
Phase 2 | |
| Completed |
NCT06374043 -
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
|
Phase 4 | |
| Completed |
NCT03396328 -
Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria
|
N/A | |
| Not yet recruiting |
NCT06094920 -
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
|
Phase 4 | |
| Recruiting |
NCT00342927 -
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
|
||
| Completed |
NCT02689778 -
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
|
Phase 3 | |
| Completed |
NCT02497300 -
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
|
Phase 2 | |
| Completed |
NCT02446548 -
Influence of Aliskiren on Albuminuria After Kidney Transplantation
|
N/A | |
| Completed |
NCT01547897 -
NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria
|
Phase 2 | |
| Enrolling by invitation |
NCT01316068 -
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
|
Phase 4 |